References
- Duncan L. J. P., Rose K., Meiklejohn A. P. Phenmetrazine hydrochloride and methylcellulose in the treatment of refractory obesity. Lancet 1960; 1: 12621. Duncan L. J. P., Rose K., Meiklejohn A. P. Phenmetrazine hydrochloride and methylcellulose in the treatment of refractory obesity. Lancet 1960; 1: 1262
- Hossain M., Campbell B. C. Fenfluramine and methylcellulose in the treatment of obesity. The relationship between plasma drug concentrations and therapeutic efficacy. Postgrad. Med. J. 1975; 51: 155, Suppl. 12. Hossain M., Campbell B. C. Fenfluramine and methylcellulose in the treatment of obesity. The relationship between plasma drug concentrations and therapeutic efficacy. Postgrad. Med. J. 1975; 51: 155, Suppl. 1
- Hudson K. D. The anorectic and hypotensive effect of fenfluramine in obesity. J. R. Coll. Gen. Pract. 1977; 27: 4973. Hudson K. D. The anorectic and hypotensive effect of fenfluramine in obesity. J. R. Coll. Gen. Pract. 1977; 27: 497
- Innes J. A., Watson M. L., Ford M. J., Munro J. F., Stoddart M. E., Campbell D. B. Plasma fenfluramine levels, weight loss and side-effects. Br. Med. J. 1977; 2: 13224. Innes J. A., Watson M. L., Ford M. J., Munro J. F., Stoddart M. E., Campbell D. B. Plasma fenfluramine levels, weight loss and side-effects. Br. Med. J. 1977; 2: 1322
- Lawson A. A. H., Strong J. A., Roscoe P., Gibson A. Comparisons of fenfluramine and metformin in treatment of obesity. Lancet 1970; 2: 4275. Lawson A. A. H., Strong J. A., Roscoe P., Gibson A. Comparisons of fenfluramine and metformin in treatment of obesity. Lancet 1970; 2: 427
- Munro J. F., MacCuish A. C., Wilson E. M., Duncan L. J. P. Comparison of continuous and intermittent anorectic therapy in obesity. Br. Med. J. 1968; 1: 3526. Munro J. F., MacCuish A. C., Wilson E. M., Duncan L. J. P. Comparison of continuous and intermittent anorectic therapy in obesity. Br. Med. J. 1968; 1: 352
- Munro J. F., Seaton D. A., Duncan L. J. P. Treatment of refractory obesity with fenfluramine. Br. Med. J. 1966; 2: 6247. Munro J. F., Seaton D. A., Duncan L. J. P. Treatment of refractory obesity with fenfluramine. Br. Med. J. 1966; 2: 624
- Seaton D. A., Duncan L. J. P., Rose K., Scott A. M. Diethylpropion in the treatment of “refractory” obesity. Br. Med. J. 1961; 1: 10098. Seaton D. A., Duncan L. J. P., Rose K., Scott A. M. Diethylpropion in the treatment of “refractory” obesity. Br. Med. J. 1961; 1: 1009
- Seaton D. A., Rose K., Duncan L. J. P. A comparison of the appetite suppressing properties of dexamphetamine and phentermine. Scott. Med. J. 1964; 9: 4829. Seaton D. A., Rose K., Duncan L. J. P. A comparison of the appetite suppressing properties of dexamphetamine and phentermine. Scott. Med. J. 1964; 9: 482
- Seaton D. A., Rose K., Duncan L. J. P. Sustained action chlorphentermine in the correction of refractory obesity. Practitioner 1964; 193: 69810. Seaton D. A., Rose K., Duncan L. J. P. Sustained action chlorphentermine in the correction of refractory obesity. Practitioner 1964; 193: 698
- Smith R. G., Innes J. A., Munro J. F. Double-blind evaluation of mazindol in refractory obesity. Br. Med. J. 1975; 3: 28411. Smith R. G., Innes J. A., Munro J. F. Double-blind evaluation of mazindol in refractory obesity. Br. Med. J. 1975; 3: 284
- Steel J. M., Briggs M. Withdrawal depression in obese patients after fenfluramine treatment. Br. Med. J. 1972; 3: 2612. Steel J. M., Briggs M. Withdrawal depression in obese patients after fenfluramine treatment. Br. Med. J. 1972; 3: 26
- Steel J. M., Munro J. F., Duncan L. J. P. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Practitioner 1973; 211: 23213. Steel J. M., Munro J. F., Duncan L. J. P. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Practitioner 1973; 211: 232